Literature DB >> 1737093

Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease.

J Wesierska-Gadek1, E Penner, E Hitchman, P Kier, G Sauermann.   

Abstract

Previously we observed that sera from recipients of allogeneic bone marrow transplants who developed extensive chronic graft-versus-host disease (GVHD) intensively stained the nucleolar region of target cells in indirect immunofluorescence microscopy. To identify the target antigens, immunoblotting experiments were performed using isolated nuclei, isolated nucleoli, and purified nuclear and nucleolar proteins as the antigen source. The nucleolar phosphoproteins B23 and C23 were identified as the main target antigens. Eleven of 19 extensive chronic GVHD sera reacted with these nucleolar phosphoproteins. In addition, four sera recognized histone H1, and two sera recognized the nuclear lamins A and C. Our patients reacting with the nucleolar proteins had symptoms resembling that of scleroderma or Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737093

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.

Authors:  Bing Hao; Song Gao; Yi-Wen Sang; Lin Wang; Xue-Qin Meng; Jing-Ya You
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

2.  Langerhans' cells are depleted in chronic graft versus host disease.

Authors:  S Aractingi; E Gluckman; M C Dauge-Geffroy; C Le Goué; A Flahaut; L Dubertret; E Carosella
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

Review 3.  Chronic graft-versus-host disease: Pathogenesis and clinical management.

Authors:  José A Pérez-Simón; Ignacio Sánchez-Abarca; María Díez-Campelo; Dolores Caballero; Jesús San Miguel
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others.

Authors:  Minoru Satoh; Angela Ceribelli; Tomoko Hasegawa; Shin Tanaka
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-08       Impact factor: 10.817

5.  Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.

Authors:  Sarka Nemeckova; Kamila Alexova-Zurkova; Petr Hainz; Jitka Krystofova; Jana Mackova; Katerina Roubalova; Marketa Stastna-Markova; Milena Vrana; Jan Vydra
Journal:  Curr Oncol       Date:  2022-04-20       Impact factor: 3.109

Review 6.  The pathophysiology of chronic graft-versus-host disease.

Authors:  Emin Kansu
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490

7.  Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.

Authors:  Rupa Narayan; Niclas Olsson; Lisa E Wagar; Bruno C Medeiros; Everett Meyer; Debra Czerwinski; Michael S Khodadoust; Lichao Zhang; Liora Schultz; Mark M Davis; Joshua E Elias; Ron Levy
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

8.  Antinuclear antibodies produced in HLA-DR transgenic humanized mice developed chronic graft-versus-host disease.

Authors:  Hiroshi Tsuzuki; Yasuko Nagatsuka; Mitsuhiro Iwata; Noboru Kitamura; Yosuke Nagasawa; Taro Matsumoto; Ryoji Ito; Takeshi Takahashi; Mamoru Ito; Hideki Nakamura; Masami Takei
Journal:  Heliyon       Date:  2021-11-11

9.  Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210.

Authors:  J Wesierska-Gadek; H Hohenauer; E Hitchman; E Penner
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

Review 10.  Conventional and nonconventional roles of the nucleolus.

Authors:  Mark O J Olson; Kamini Hingorani; Attila Szebeni
Journal:  Int Rev Cytol       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.